3.95
Burning Rock Biotech Ltd Adr stock is traded at $3.95, with a volume of 72,989.
It is down -7.49% in the last 24 hours and down -34.28% over the past month.
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
See More
Previous Close:
$4.27
Open:
$4
24h Volume:
72,989
Relative Volume:
7.93
Market Cap:
$40.52M
Revenue:
$71.19M
Net Income/Loss:
$-59.54M
P/E Ratio:
-0.6802
EPS:
-5.8068
Net Cash Flow:
$-18.58M
1W Performance:
-15.96%
1M Performance:
-34.28%
6M Performance:
+10.34%
1Y Performance:
-48.62%
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Name
Burning Rock Biotech Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare BNR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BNR
Burning Rock Biotech Ltd Adr
|
3.95 | 40.52M | 71.19M | -59.54M | -18.58M | -5.8068 |
![]()
TMO
Thermo Fisher Scientific Inc
|
470.03 | 177.32B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
197.90 | 141.59B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
IDXX
Idexx Laboratories Inc
|
410.76 | 33.29B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
109.67 | 31.28B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
167.69 | 29.57B | 15.41B | 1.37B | 2.11B | 7.50 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-15-21 | Resumed | Cowen | Outperform |
Jul-07-20 | Initiated | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Stock (BNR) Latest News
Burning Rock Biotech LtdADR to Host Earnings Call - ACCESS Newswire
Burning Rock Announces Results of 2024 Annual General Meeting - Marketscreener.com
Burning Rock Announces Results of 2024 Annual General Meeting - GlobeNewswire Inc.
Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Canada Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech CFO Leo Li resigns - Investing.com
Burning Rock Biotech Limited Announces the Resignation of Leo Li as Chief Financial Officer - Marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Viant Technology (DSP) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Burning Rock Biotech Limited Sponsored ADR (BNR) Reports Q2 Loss, Tops Revenue Estimates - Nasdaq
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - USC-China Institute
Transcript : Burning Rock Biotech Limited, Q4 2021 Earnings Call, Mar 22, 2022 - Marketscreener.com
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
Burning Rock (BNR) in Focus: Stock Moves 5.4% Higher - Yahoo Finance
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga
Burning Rock Biotech Ltd Adr Stock (BNR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):